KANUMA 2 mg/mL
Sebelipase alfa · INJECTION, SOLUTION, CONCENTRATE · Alexion Pharmaceuticals, Inc.
KANUMA is a injection, solution, concentrate containing sebelipase alfa at 2 mg/mL, taken intravenous. Manufactured by Alexion Pharmaceuticals, Inc..
Key Facts
- Brand Name
- KANUMA
- Generic Name
- Sebelipase alfa
- NDC Code (Product)
25682-007- Manufacturer
- Alexion Pharmaceuticals, Inc.
- Strength
- 2 mg/mL
- Dosage Form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125561
- Drug Class
- Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC]; Hydrolytic Lysosomal Triacylglycerol-specific Enzyme [EPC]
- Marketing Start
- 12/08/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is KANUMA used for?
KANUMA contains Sebelipase alfa. It is a injection, solution, concentrate taken intravenous. Consult your doctor for specific uses.
Is KANUMA a controlled substance?
KANUMA is not classified as a controlled substance by the DEA.
What is the generic name for KANUMA?
The generic name for KANUMA is Sebelipase alfa. There are no other listed brand versions of Sebelipase alfa.
What is the NDC code for KANUMA 2 mg/mL?
The NDC (National Drug Code) for KANUMA 2 mg/mL is 25682-007, listed by Alexion Pharmaceuticals, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)